![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Clears Ceterix’s Suture Cartridge
FDA Clears Ceterix’s Suture Cartridge
![ClearanceStamp_Orange.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Orange.gif?t=1609798625&width=430)
August 29, 2018
The FDA granted 510(k) clearance for an additional feature of Ceterix Orthopaedics’ NovoStitch Pro Meniscal Repair System, a device used in repairing meniscal tears.
The device is used to place stitches arthroscopically within tight joint areas and allows surgeons to work on meniscal tears that previously responded poorly to repairs.
The cleared feature, a size zero suture cartridge, gives surgeons expanded options in suture size and enables them to pass a complete stitch in the knee joint without having to remove the device to reload a suture.
Upcoming Events
-
21Oct